MAKING HEARING A PRIORITY
CILcare is the world’s leading R&D services company committed to making hearing a priority. Take an in-depth look at how we can support your R&D program to prevent and treat ear disorders.
Discover our services
Treating underlying cardiovascular disease may prevent or slow the progression of hearing loss, and conversely, hearing loss may suggest underlying cardiovascular disease. Discover a recent publication describing the association between cardiavascular disease and...
Meet CILcare's CEO Celia Belline at the Annual meeting of preclinical research in Marseille Round table: International Perspective July 2, 2018 | 4 PM Pitch session #3 July 3, 2018 | 3:30 PM The Annual meetings of preclinical research: The AFSSI organizes in...
Age-related disorders, CILcare and Amylgen partner to propose unique preclinical models to assess the effects of health solutions on hearing and cognitive functions ! It is established that hearing loss is one of the three major risk factors for dementia and is...
Pharma / Biotech
Develop new therapies. Repurpose existing drugs in otology.
Innovate with drug delivery devices for the inner ear. Speed up market access of hearing aids.
Develop health food ingredients for the prevention of hearing loss, tinnitus, or otitis.
Improve and develop products to treat ear inflammation in pets.
CILcare, the world leading CRO dedicating to ear disorders
CILcare is a unique R&D services company specialized in ear disorders. We offer preclinical services and consultancy to accelerate the development of innovative products for hearing loss, tinnitus, and otic disorders.